Publications

Detailed Information

The correlation between poor prognosis and increased yes-associated protein 1 expression in keratin 19 expressing hepatocellular carcinomas and cholangiocarcinomas

DC Field Value Language
dc.contributor.authorLee, KyuHo-
dc.contributor.authorLee, Kyoung-Bun-
dc.contributor.authorJung, Hae Yoen-
dc.contributor.authorYi, Nam-Joon-
dc.contributor.authorLee, Kwang-Woong-
dc.contributor.authorSuh, Kyung-Suk-
dc.contributor.authorJang, Ja-June-
dc.date.accessioned2017-07-05T07:47:40Z-
dc.date.available2017-07-24T11:33:39Z-
dc.date.issued2017-06-23-
dc.identifier.citationBMC Cancer, 17(1):441ko_KR
dc.identifier.issn1471-2407-
dc.identifier.issn1471-2407-
dc.identifier.uri10.1186/s12885-017-3431-1-
dc.identifier.urihttps://hdl.handle.net/10371/117762-
dc.description.abstractBackground
The Hippo pathway plays a vital role in liver regeneration and development by determining cellular lineage and regulating cell proliferation and apoptosis. In this study, we aimed to assess the role of the Hippo pathway in hepatic carcinogenesis and morphogenesis by examining Yes-associated protein 1 (YAP1) expression in the spectrum of hepatic carcinomas based on cellular lineage.

Methods
We examined 913 primary hepatic carcinomas, including hepatocellular carcinomas (HCCs), combined hepatocellular and cholangiocarcinomas (cHC-CCAs), intrahepatic cholangiocarcinomas (IHCCAs) and perihilar extrahepatic bile duct carcinomas (EHBCAs). Our study group was categorized into 8 disease groups, based on histological diagnosis and cytokeratin 19 (CK19) expression, and immunohistochemistry was used to detect and compare YAP1 expression levels between the groups. The eight disease groups we identified were: 1) CK19(−) HCC, 2) CK19(−) scirrhous HCC, 3) CK19(+) HCC, 4) stem cell feature of cHC-CCA, 5) classical cHC-CCA, 6) cholangiolocellular IHCCA, 7) non-cholangiolocellular IHCCA, and 8) EHBCA.

Results
Positive rates of YAP1 were the highest in the EHBCA group (21%). CK19(+) HCC and non-cholangiolocellular IHCCA groups also showed high expression levels (10% -11%), while the CK19 (−) HCC, CK19 (−) scirrhous HCC, cHC-CCA, and cholangiolocellular IHCCA groups showed low expression levels, ranging between 0% and 5%. Survival analysis, restricted to pT1 stage HCCs and IHCCAs, showed poor overall survival for YAP1(+) IHCCA patients (39±17 vs. 109±10months, mean±SD, log rank p-value 0.005). For HCCs, a trend of poor progression-free survival for YAP1(+) HCCs was observed (39±18 vs. 81±5months, mean±SD, log rank p-value 0.205)

Conclusions
YAP1 activation was more commonly found in CCAs than in pure HCCs. However, a differing pattern of YAP1 expression between cHC-CCAs and CK19(+) HCCs and the poor prognosis of YAP1 positive hepatic carcinomas suggests that YAP1 may have a preferential role in aggressive tumor behavior, rather than in the determination of cellular lineage in hepatic carcinomas.
ko_KR
dc.language.isoenko_KR
dc.publisherBioMed Centralko_KR
dc.subjectYAP1ko_KR
dc.subjectHepatocellular carcinomako_KR
dc.subjectCholangiocarcinomako_KR
dc.subjectCombined hepatocellular and cholangiocarcinomako_KR
dc.subjectProgenitor cellko_KR
dc.titleThe correlation between poor prognosis and increased yes-associated protein 1 expression in keratin 19 expressing hepatocellular carcinomas and cholangiocarcinomasko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor이규호-
dc.contributor.AlternativeAuthor이경분-
dc.contributor.AlternativeAuthor정혜연-
dc.contributor.AlternativeAuthor이남준-
dc.contributor.AlternativeAuthor이광웅-
dc.contributor.AlternativeAuthor서경석-
dc.contributor.AlternativeAuthor장자연-
dc.language.rfc3066en-
dc.rights.holderThe Author(s).-
dc.date.updated2017-06-25T03:21:33Z-
Appears in Collections:
Files in This Item:

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share